MUC-1 antigen with reduced number of VNTR repeat units

Details for Australian Patent Application No. 2003240729 (hide)

Owner Glaxo Group Limited

Inventors Hamblin, Paul A.; Ellis, Jonathan Henry; Burden, Neil

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003240729

PCT Number PCT/EP03/05594

PCT Pub. Number WO2003/100060

Priority 0212046.7 24.05.02 GB

Filing date 23 May 2003

Wipo publication date 12 December 2003

Acceptance publication date 20 December 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 0212046.7 24.05.02 GB

5 February 2004 Application Open to Public Inspection

  Published as AU-B-2003240729

20 December 2007 Application Accepted

  Published as AU-B-2003240729

24 April 2008 Standard Patent Sealed

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003240730-MORPHOLINYLMETHYLUREAS CCR3 RECEPTOR ANTAGONIST

2003240728-TRANSITION METAL COMPOUNDS THEIR PREPARATION AND THEIR USE IN CATALYST SYSTEMS FOR THE POLYMERIZATION AND COPOLYMERIZATION OF OLEFINS